Holdings of Portfolio Building Block World Pharma and Biotech Index ETF
Tidal Trust IV · Original filing · Compare with another fund · Report an error
- Net assets
- 952.2M $ including 901.9M $ in equities, 94.7 %
- Positions
- 52 in 12 countries
- Top ten
- 60.4 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 125,960 | 144.7M $ | 15.20 % |
| 2 | Johnson & Johnson | 358,759 | 92M $ | 9.66 % |
| 3 | AbbVie Inc | 263,508 | 66.1M $ | 6.94 % |
| 4 | Merck & Co Inc | 368,345 | 48M $ | 5.04 % |
| 5 | Amgen Inc | 114,594 | 44.1M $ | 4.64 % |
| 6 | Novartis AG | 272,287 | 42.6M $ | 4.47 % |
| 7 | AstraZeneca PLC | 218,231 | 37.1M $ | 3.90 % |
| 8 | Gilead Sciences Inc | 275,847 | 35.9M $ | 3.77 % |
| 9 | Novo Nordisk A/S | 708,402 | 33.4M $ | 3.51 % |
| 10 | Pfizer Inc | 1,266,224 | 31.7M $ | 3.33 % |
| 11 | Bristol-Myers Squibb Co | 453,416 | 29.6M $ | 3.11 % |
| 12 | Vertex Pharmaceuticals Inc | 56,247 | 26.8M $ | 2.82 % |
| 13 | GSK PLC | 827,662 | 21.5M $ | 2.26 % |
| 14 | Sanofi SA | 241,243 | 20.7M $ | 2.17 % |
| 15 | Regeneron Pharmaceuticals Inc | 22,298 | 17M $ | 1.79 % |
| 16 | Bayer AG | 218,254 | 12.1M $ | 1.27 % |
| 17 | Takeda Pharmaceutical Co Ltd | 343,901 | 11.9M $ | 1.25 % |
| 18 | Argenx SE | 13,776 | 11.8M $ | 1.24 % |
| 19 | CSL Ltd | 122,349 | 10.6M $ | 1.11 % |
| 20 | Teva Pharmaceutical Industries Ltd | 257,121 | 9.1M $ | 0.96 % |
| 21 | NATERA INC | 30,087 | 8.1M $ | 0.85 % |
| 22 | Sandoz Group AG | 90,803 | 7.4M $ | 0.78 % |
| 23 | REVOLUTION MEDICINES INC | 39,316 | 7.4M $ | 0.77 % |
| 24 | Zoetis Inc | 93,270 | 7.2M $ | 0.76 % |
| 25 | Illumina Inc | 33,633 | 6.9M $ | 0.72 % |
| 26 | UCB SA | 26,737 | 6.9M $ | 0.72 % |
| 27 | Biogen Inc | 32,847 | 6.7M $ | 0.70 % |
| 28 | Otsuka Holdings Co Ltd | 91,224 | 6.4M $ | 0.67 % |
| 29 | Chugai Pharmaceutical Co Ltd | 138,993 | 6.1M $ | 0.64 % |
| 30 | Haleon PLC | 1,237,051 | 6M $ | 0.64 % |
| 31 | ALNYLAM PHARMACEUTICALS INC | 29,349 | 6M $ | 0.63 % |
| 32 | Daiichi Sankyo Co Ltd | 365,422 | 5.9M $ | 0.62 % |
| 33 | Incyte Corp | 44,808 | 5.4M $ | 0.56 % |
| 34 | Astellas Pharma Inc | 385,185 | 5.3M $ | 0.56 % |
| 35 | United Therapeutics Corp | 9,404 | 4.9M $ | 0.51 % |
| 36 | ROYALTY PHARMA PLC | 83,179 | 4.9M $ | 0.51 % |
| 37 | Merck KGaA | 28,653 | 4.7M $ | 0.50 % |
| 38 | Insmed Inc | 46,715 | 4.6M $ | 0.48 % |
| 39 | VIATRIS INC | 256,625 | 4.5M $ | 0.47 % |
| 40 | MODERNA INC | 78,235 | 4.3M $ | 0.45 % |
| 41 | Genmab A/S | 13,254 | 3.8M $ | 0.40 % |
| 42 | Neurocrine Biosciences Inc | 22,193 | 3.7M $ | 0.39 % |
| 43 | Roivant Sciences Ltd | 107,395 | 3.6M $ | 0.38 % |
| 44 | JAZZ PHARMACEUTICALS PLC | 13,582 | 3.4M $ | 0.36 % |
| 45 | ELANCO ANIMAL HEALTH INC | 112,523 | 3M $ | 0.31 % |
| 46 | Roche Holding AG | 6,684 | 3M $ | 0.31 % |
| 47 | Shionogi & Co Ltd | 160,184 | 2.9M $ | 0.31 % |
| 48 | Exelixis Inc | 54,638 | 2.9M $ | 0.30 % |
| 49 | Bridgebio Pharma Inc | 32,623 | 2.6M $ | 0.27 % |
| 50 | Galderma Group AG | 11,886 | 2.6M $ | 0.27 % |
| 51 | BioMarin Pharmaceutical Inc | 42,787 | 2.6M $ | 0.27 % |
| 52 | IONIS PHARMACEUTICALS INC | 33,908 | 1.8M $ | 0.18 % |
Sector breakdown
- Health care 88.7 %
- Consumer staples 0.7 %
- Unattributed 10.6 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 69.9 %
- GBP 7.2 %
- EUR 6.2 %
- CHF 6.2 %
- JPY 4.3 %
- DKK 4.1 %
- AUD 1.2 %
- ILS 1.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 69.1 %
- United Kingdom 7.2 %
- Switzerland 6.2 %
- Japan 4.3 %
- Denmark 4.1 %
- France 2.3 %
- Belgium 2.1 %
- Germany 1.9 %
- Australia 1.2 %
- Israel 1.0 %
- Bermuda 0.4 %
- Ireland 0.4 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 28 | 623.2M $ | 69.09 % |
| 2 | United Kingdom | 3 | 64.7M $ | 7.17 % |
| 3 | Switzerland | 4 | 55.5M $ | 6.16 % |
| 4 | Japan | 6 | 38.5M $ | 4.26 % |
| 5 | Denmark | 2 | 37.2M $ | 4.13 % |
| 6 | France | 1 | 20.7M $ | 2.29 % |
| 7 | Belgium | 2 | 18.7M $ | 2.07 % |
| 8 | Germany | 2 | 16.8M $ | 1.86 % |
| 9 | Australia | 1 | 10.6M $ | 1.17 % |
| 10 | Israel | 1 | 9.1M $ | 1.01 % |
| 11 | Bermuda | 1 | 3.6M $ | 0.40 % |
| 12 | Ireland | 1 | 3.4M $ | 0.38 % |
Cite this page
Titelia. "Holdings of Portfolio Building Block World Pharma and Biotech Index ETF". https://titelia.com/en/funds/S000096308